Addition of nintedanib or placebo to neoadjuvant gemcitabine and cisplatin in locally advanced muscle-invasive bladder cancer (NEOBLADE): a double-blind, randomised, phase 2 trial by Hussain, Syed A, Prof, Lester, Jason F, FRCR, Jackson, Richard, PhD, Gornall, Matthew, BSc, Qureshi, Muneeb, FRCR, Elliott, Anthony, PhD, Crabb, Simon J, PhD, Huddart, Robert A, Prof, Vasudev, Naveen, PhD, Birtle, Alison J, Prof, Worlding, Jane, FRCR, James, Nicholas D, Prof, Parikh, Omi, FRCR, Vilarino-Varela, Maria, FRCR, Alonzi, Roberto, MD, Linch, Mark D, PhD, Riaz, Irbaz B, MD, Catto, James W F, Prof, Powles, Thomas, Prof, Jones, Robert J, Prof

Get full text